RecruitingNCT07136207

Development and Validation of Delirium Recognition Using Computer Vision in Neuro-critical Patients

Research on Delirium Recognition in Neurocritical Patients Based on Facial Expression Behavior Patterns


Sponsor

Beijing Tiantan Hospital

Enrollment

1,000 participants

Start Date

Aug 30, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This research project employs machine learning algorithms integrated with computer vision, image processing, and pattern recognition technologies to perform digital analysis of facial expression behaviors in neurocritical care patients with delirium. By constructing multidimensional high-level features of delirium, the investigators have established a classification model based on behavioral. The primary objective of this study is to address the critical challenge of achieving precise and efficient delirium diagnosis in neurologically critically ill patients through automated facial expression behavior recognition.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria3

  • Neurocritical patients admitted to the ICU, including postoperative neurosurgical patients, stroke patients, and those receiving ICU care due to other neurological conditions.
  • Age over 18 years.
  • Signed informed consent.

Exclusion Criteria5

  • Age under 18 years.
  • Persistent coma (GCS ≤ 8) within 7 days pre- and post-surgery, making delirium assessment impossible.
  • Did not survive more than 24 hours in the ICU.
  • Patients with facial paralysis, post-traumatic facial disfigurement, or other conditions that could significantly affect facial recognition.
  • Exclusion of patients with severe dementia, Parkinson's disease, depression, or other conditions that might impact facial emotional expressions.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Beijing Tiantan Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07136207


Related Trials